Industry Breakout Sessions

Proof of vaccination is required to attend AMGA’s 2022 Annual Conference. You must be fully vaccinated according to CDC guidelines and upload your information to our third-party vendor before picking up your badge in Las Vegas.

Corporate Partner Breakout Sessions

These 60-minute concurrent breakout sessions,* designed by AMGA Corporate Partners and featuring AMGA member speakers and panelists, highlight the collaborative partnerships between these two groups. Sessions will be presented on Thursday, March 10, from 10:30 to 11:30 a.m.

If you are an AMGA Corporate Partner and would like to learn more about this opportunity, please contact Colleen Stern, director of corporate relations.

*These sessions are for medical group attendees only.

Exact Sciences (Sponsor)

Targeted Tech, Magnified Effect: Leveraging Digital and Technology Optimizations to Increase Cancer Screening Rates

Early cancer detection is a key component of health systems’ prevention capabilities and population health initiatives. With many competing priorities, it’s critical to take the friction out of screening to get as many patients screened as possible. Across the country, health systems of all sizes and scopes are taking advantage of digital capabilities and health information technology optimizations to increase screening rates, improve patient experience, reduce provider burnout and meet quality metrics. Join this session to learn directly from health system leaders who will outline opportunities and key success factors on how to target tech-based solutions for a magnified effect on improving CRC screening rates.

Cybele Pacheco, MD, MBA, FAAFP, Medical Director, Geisinger Health System

Katie Lawrence, MHA, CMPE, Executive Director, Ambulatory Optimization & Integration, Prisma Health Medical Group

Kaitlin May, MBA, Population Health Supervisor, Yale New Haven Health – Northeast Medical Group

Maggie Shalagan, MAS, Manager, Population Health, Yale New Haven Health – Northeast Medical Group

Moderator: Durado D Brooks, MD, MPH, Deputy Chief Medical Officer, Screening, Exact Sciences

This session is for medical group attendees only.

Exact Sciences (Sponsor)

Older Adults with Diabetes: Reduce the Risk of Hypoglycemia with Real-Time Continuous Glucose Monitoring

Over 25% of U.S. adults 65 years of age and older have diabetes.1 And this number is expected to increase in the coming decades.1 Older adults with diabetes are at a greater risk for hypoglycemia. Traditional self-monitoring of blood glucose may not be ideal for older adults who experience nocturnal and asymptomatic hypoglycemia. The ADA Standards of Medical Care in Diabetes state continuous glucose monitoring should be considered for older adults with type 1 diabetes to reduce hypoglycemia and an option for older adults with type 2 diabetes using multiple daily injections of insulin.2 Also, the AACE Clinical Practice Guidelines recommend real-time continuous glucose monitoring (RT-CGM) for individuals 65 years and older with insulin requiring diabetes.3
This presentation will share the latest research to support the use of RT-CGM to reduce time spent in hypoglycemia and improve A1C compared to fingerstick monitoring in the older adult population. Through a case study, we will follow an older adult with type 2 diabetes and identify why RT-CGM is appropriate. Then we will configure the Dexcom G6 alerts, and Dexcom CLARITY trend features to improve glycemic outcomes and time in range. Finally, we will collaborate using shared decision-making to modify the treatment plan.
Michele Laine, APRN, CDCES, Nurse Practitioner, Certified Diabetes Care and Education Specialist, Florida Medical Clinic Endocrinology
1Rao H, et al. Sr Care Pharm. 2021;36:556-567.
2American Diabetes Association.12. Older adults: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021; 44  (Suppl.1):S168-S179.
3Grunberger G, et al. Endocr Pract. 2021; 27(6):505-537.

This session is for medical group attendees only.

Exact Sciences (Sponsor)

Belonging as a Burnout Countermeasure

Our industry continues to suffer from unprecedented challenges and burnout, creating staffing instability that threatens care delivery. The question constantly circulates, "what do we do to lift spirits and retain talent?" In this session, Stephen Beeson MD dives into the actionable approach of advancing a culture of belonging. Dr. Beeson will dive into the benefits of belonging and share simple, accessible actions to promote a "we are here for each other" environment and how that can serve as a powerful burnout countermeasure.

Stephen Beeson, M.D., Founder and CEO, Practicing Excellence

This session is for medical group attendees only.

Pfizer (Sponsor)

Burden of More than Just Heart Failure: Why Prioritize ATTR-CM Within Your Health System

In a roundtable discussion with Dr. Clement C. Eiswirth, Jr., MD, FACC, FASE and Dr. David Wolinsky, MD FACC MASNC, Lori Baylor, PhD will discuss transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, fatal, and underdiagnosed disease that can lead to heart failure. The discussion will highlight how two health systems are navigating the identification and management of patients with ATTR-CM across the Multi-Disciplinary team, as well as a Q and A session regarding ATTR-CM prioritization within a health system

Dr. David Wolinsky, M.D., FACC, MASNC, Director Cardiac Amyloid Center, Section Head Nuclear cardiology, Cleveland Clinic Florida

Clement C. Eiswirth, Jr., M.D., FACC, FASE, Director of the Cardiomyopathy and Heart Failure Program, Medical Director of the Coronary Care Unit, Medical Director of the Transition of Care Clinic, Ochsner Medical Center, New Orleans, LA

Moderator: Lori. M. Baylor, Ph.D., Medical Director, Rare Cardiology, Pfizer, Inc. 

This session is for medical group attendees only.

Pfizer (Sponsor)

Communication is Key: Improving Care Transitions in Patients with VTE

Primary treatment for VTE, manifesting as deep-vein thrombosis (DVT) and pulmonary embolism (PE), continues for 3-6 months, and secondary prevention may be indicated thereafter. A Transitions of Care Plan and communication is essential to ensuring treatment is carried out across the multiple points of care to avoid hospital admission or readmission. This session will feature an AMGA-member panel where clinician experts in caring for patients with VTE and will share their strategies to better manage transitions of care for these patients across inpatient, outpatient, emergent, and long-term care settings. In addition to structure and process strategies, the discussion will also emphasize the importance of communication and relationships across care settings and strategies to improve them.

Nancy C. MacDonald, Pharm.D., BCPS, FASHP, Coordinator, Transitions of Care & Emergency Preparedness, Department of Pharmacy Services, Henry Ford Hospital

Rae Ann Williams, M.D., FACP, Regional Medical Director, Primary Care, HealthPartners Medical Group

Moderator: Elizabeth Ciemins, Ph.D., M.P.H., M.A., Vice President, Research and Analytics, AMGA           

This session is for medical group attendees only.